NBFIs on ‘strongest footing in years’
'Lack of domestic investment was not always the case'
Strategic shift carries 'major implications'
Questions on whether bar is set high enough
Five big biotech themes
Opportunities beyond saturated US
Rate cut predicted in September
Ideal time for UK Growth ISA